Bioterrorism law and policy: Critical choices in public health

Journal of Law, Medicine and Ethics

Volumn 30, Issue 2, 2002, Pages 254-261

  Hodge Jr , James G ^a,b,c,d  

^a GEORGETOWN UNIVERSITY LAW CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; CONFERENCE PAPER; CORRELATION ANALYSIS; CRIMINAL BEHAVIOR; DECISION MAKING; DISEASE CONTROL; FEASIBILITY STUDY; FIRST AID; GENERAL PRACTITIONER; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; LAW; LEGAL ASPECT; MEDICAL PRACTICE; PUBLIC HEALTH; SAFETY; TECHNIQUE; TERRORISM; UNITED STATES; ARTICLE; DISASTER PLANNING; HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH; POLICY; WAR AND HUMAN RIGHTS ABUSES;

HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH; WAR AND HUMAN RIGHTS ABUSES;

BIOTERRORISM; DISASTER PLANNING; HUMANS; PUBLIC HEALTH; PUBLIC POLICY; UNITED STATES;

EID: 0036598602     PISSN: 10731105     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2002.tb00391.x     Document Type: Conference Paper

References (57)

1. L.O. Gostin, Public Health Law: Power, Duty, Restraint (Berkeley: University of California Press, 2000): at 16.
2. E. Lipton, "Hard to Figure: A Difference in the Numbers," New York Times, October 25, 2001, at B1.
3. Model State Emergency Health Powers Act § 1-104(a) (December 21, 2001), available at 〈http://www.publichealthlaw.net/MSEHPA/MSEHPA2. pdf〉. The Act can also be found on pages 324-348 of this issue.
4. D.E. Shalala, "Bioterrorism: How Prepared Are We?," Emerging Infectious Diseases, 5, no. 4 (1999): 492-93, available at 〈http://www.cdc. gov/ncidod/EID/vol5no4/shalala.htm〉.
5. T. Inglesby, R. Grossman, and T. O'Toole, "A Plague on Your City: Observations from TOPOFF," Biodefense Quarterly, 2 (2000): 1-10.
6. M. Freudenheim, "Few Hospitals Are Ready for a Surge of Bioterror Victims," New York Times, October 26, 2001, at B8.
7. S. Khan and D.A. Ashford, "Ready or Not - Preparedness for Bioterrorism," N. Engl. J. Med., 345 (2001): 287-89.
8. D.E. Rosenbaum and S.G. Stolberg, "New Battlefield: Questions on Adequacy of Health System and Public Protection," New York Times, October 23, 2001, at A1.
9. R. Weiss, "Anthrax Testing Shaky," Pittsburgh Post-Gazette, October 16, 2001, at A4.
10. J. Fialka et al., "Are We Prepared for the Unthinkable?," Wall Street Journal, September 18, 2001, at B1.
11. Public Health Threats and Emergencies Act, Pub. L. No. 106-505, 114 Stat. 2314 (2000).
12. J. Miller and S.G. Stolberg, "Sept. 11 Attacks Led to Push for More Smallpox Vaccine," New York Times, October 22, 2001, at A1.
13. Shalala, supra note 4.
14. D.P. Fidler, " Legal Issues Surrounding Public Health Emergencies." Paper presented at the Second Annual Symposium on Medical and Public Health Response to Bioterrorism, Baltimore, November 28-29, 2000.
15. Colo. Rev. Stat. Ann. § 24-32-2103 (West 2001).
16. T. Bertrand et al., The Emergence of Bioterrorism as a Public Health Concern in the 21st Century: Epidemiology and Surveillance, at 〈http://www.healthri.org/environment/biot/article.htm〉 (last updated October 15, 2001).
17. Khan and Ashford, supra note 7.
18. Model State Emergency Health Powers Act (December 21, 2001).
19. These thirty-two states are Arizona, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Kansas, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, New York, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Tennessee, Utah, Vermont, Washington, Wisconsin, and Wyoming. Center for Law and the Public's Health, Model State Emergency Health Powers Act State Legislative Activity (April 8, 2002), available at 〈http://www. publichealthlaw.net/MSEHPA/MSEHPA_Legis_Act.pdf〉.
20. B. Kellman, "Biological Terrorism: Legal Measures for Preventing Catastrophe," Harvard Journal of Law and Public Policy, 24 (2001): 417-88.
21. R.S. Root-Bernstein, "Infectious Terrorism," The Atlantic Monthly, 267 (1991): 44-50.
22. Y. Alexander, "Terrorism in the Twenty-First Century: Threats and Responses," DePaul Business Law Journal, 12 (2000): 59-81.
23. J.B. Tucker, "Historical Trends Related to Bioterrorism: An Empirical Analysis," Emerging Infectious Diseases, 5, no. 4 (1999): 498-504, at 503, available at 〈http://www.cdc.gov/ncidod/eid/vol5no4/ tucker.htm〉.
24. C. Haberman, "New Legal Powers, Fresh Anthrax Worries, Resilient Taliban," New York Times, October 26, 2001, at B1.
25. J. Miller and S.G. Stolberg, "Wider Anthrax Monitoring; U.S. Officials Acknowledge Underestimating Mail Risks," New York Times, October 25, 2001, at A1.
26. J. Lancaster and S. Schmidt, "31 Exposed to Anthrax on Capitol Hill," Washington Post, October 18, 2001, at A1.
27. Fialka et al., supra note 10.
28. L. Parker, T. Watson, and K. Johnson, "Anthrax Incidents Create Growing Sense of Anxiety," USA Today, October 15, 2001, at A1.
29. "Snapshot," USA Today, October 25, 2001, at 1A.
30. M.G. Kortepeter and G.W. Parker, "Potential Biological Weapons Threats," Emerging Infectious Diseases, 5 (1999): 523-27.
31. Ibid. Id.
32. D.A. Henderson, "Smallpox: Clinical and Epidemiologic Features," Emerging Infectious Diseases, 5, no. 4 (1999): 537-39, available at 〈http://www.cdc.gov/ncidod/EID/vol5no4/henderson.htm〉.
33. D.T. Dennis et al., "Tularemia as a Biological Weapon," JAMA, 285 (2001): 2763-73.
34. T. Inglesby et al., "Plague as a Biological Weapon," JAMA, 283 (2000): 2281-90.
35. Fialka et al., supra note 10.
36. L.K. Altman, "On Many Fronts, Experts Plan for the Unthinkable: Biowarfare," New York Times, October 23, 2001, at D4.
37. J.G. Hodge, "The Role of New Federalism and Public Health Law," Journal of Law & Health, 12 (1998): 309-57.
38. "Dark Winter," available online at 〈http://www. homelandsecurity.org/darkwinter/index.cfm〉.
39. Hodge, supra note 37.
40. Model State Emergency Health Powers Act § 1-104(m) (December 21, 2001).
41. Id. § 1-104(a).
42. J.G. Hodge and L.O. Gostin, "Handling Cases of Willful Exposure Through HIV Partner Counseling and Referral Services," Rutger's Women's Rights Law Reporter, 22 (forthcoming 2002).
43. Gostin, supra note 1, at 34-46.
44. Letter from John J. Hamre, president and chief executive officer of the Center for Strategic and International Studies, dated July 26, 2001 (referring to findings from "Dark Winter" exercise in June, 2001).
45. Shalala, supra note 4.
46. C. Connolly and S. Gray, "Thompson Seeks $1.2 Billion to Expand Stockpile of Drugs," Washington Post, October 18, 2001, at A19.
47. E.L. Andrews, "Bayer Is a Bit Taken Aback by the Frenzy to Get Its Drug," New York Times, October 26, 2001, at B8.
48. V. Sutton, "Bioterrorism Preparation and Response Legislation - The Struggle to Protect States' Sovereignty While Preserving National Security," Georgetown Public Policy Review, 6 (2001): 92-103.
49. J. Lancaster and S. Schmidt, "31 Exposed to Anthrax on Capitol Hill," Washington Post, October 18, 2001, at A1.
50. R. Willing, "Anti-Terror Bill Extends Government's Reach," USA Today, October 25, 2001, at 7A.
51. Hodge and Gostin, supra note 42.
52. Model State Emergency Health Powers Act § 604 (December 21, 2001).
53. Id. § 603.
54. Jacobson v. Massachusetts, 197 U.S. 11 (1905).
55. Gostin, supra note 1, at 213-16.
56. Model State Emergency Health Powers Act § 604 (December 21, 2001).
57. Rosenbaum and Stolberg, supra note 8.